165 related articles for article (PubMed ID: 31764519)
1. Neurocutaneous Melanocytosis and Leptomeningeal Melanoma.
Mitre V; Heym K; Clark GD; Venkatramani R
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e195-e197. PubMed ID: 31764519
[TBL] [Abstract][Full Text] [Related]
2. CSF cytology diagnosis of NRAS-mutated primary leptomeningeal melanomatosis with neurocutaneous melanosis.
Kolin DL; Geddie WR; Ko HM
Cytopathology; 2017 Jun; 28(3):235-238. PubMed ID: 27696542
[No Abstract] [Full Text] [Related]
3. NRAS
Girolami I; Cima L; Ghimenton C; Zannoni M; Mombello A; Riva G; Cirielli V; Corradi G; Vogrig A; Di Stefano G; Novelli L; Gessi M; Eccher A
Brain Tumor Pathol; 2018 Oct; 35(4):217-223. PubMed ID: 30145692
[TBL] [Abstract][Full Text] [Related]
4. Rapid response to therapy of neurocutaneous melanosis with leptomeningeal melanoma.
Subbiah V; Wolff JE
Pediatr Blood Cancer; 2010 Jan; 54(1):180-1. PubMed ID: 19722276
[No Abstract] [Full Text] [Related]
5. Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor.
Küsters-Vandevelde HV; Willemsen AE; Groenen PJ; Küsters B; Lammens M; Wesseling P; Djafarihamedani M; Rijntjes J; Delye H; Willemsen MA; van Herpen CM; Blokx WA
Acta Neuropathol Commun; 2014 Apr; 2():41. PubMed ID: 24713450
[TBL] [Abstract][Full Text] [Related]
6. Amplification of mutated NRAS leading to congenital melanoma in neurocutaneous melanocytosis.
Salgado CM; Basu D; Nikiforova M; Hamilton RL; Gehris R; Jakacki R; Panigrahy A; Yatsenko S; Reyes-Múgica M
Melanoma Res; 2015 Oct; 25(5):453-60. PubMed ID: 26266759
[TBL] [Abstract][Full Text] [Related]
7. Druggable targets in pediatric neurocutaneous melanocytosis: Molecular and drug sensitivity studies in xenograft and ex vivo tumor cell culture to identify agents for therapy.
Ruan Y; Kovalchuk A; Jayanthan A; Lun X; Nagashima Y; Kovalchuk O; Wright JR; Pinto A; Kirton A; Anderson R; Narendran A
Neuro Oncol; 2015 Jun; 17(6):822-31. PubMed ID: 25395461
[TBL] [Abstract][Full Text] [Related]
8. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS.
Kinsler VA; Thomas AC; Ishida M; Bulstrode NW; Loughlin S; Hing S; Chalker J; McKenzie K; Abu-Amero S; Slater O; Chanudet E; Palmer R; Morrogh D; Stanier P; Healy E; Sebire NJ; Moore GE
J Invest Dermatol; 2013 Sep; 133(9):2229-36. PubMed ID: 23392294
[TBL] [Abstract][Full Text] [Related]
9. AN 11-Year-Old Boy with a Leptomeningeal Tumor.
Habougit C; Forest F; Boutet C; Douchet C; Stephan JL; Stachowicz ML; Vassal F; Péoc'h M
Brain Pathol; 2017 Jul; 27(4):553-554. PubMed ID: 28585389
[No Abstract] [Full Text] [Related]
10. Neurocutaneous melanosis.
Di Rocco F; Sabatino G; Koutzoglou M; Battaglia D; Caldarelli M; Tamburrini G
Childs Nerv Syst; 2004 Jan; 20(1):23-8. PubMed ID: 14576958
[TBL] [Abstract][Full Text] [Related]
11. Severe hydrocephalus caused by diffuse leptomeningeal and neurocutaneous melanocytosis of antenatal onset: a clinical, pathologic, and molecular study of 2 cases.
Uguen A; Laurent C; Samaison L; Boisselier B; Talagas M; Costa S; Aziza J; Mokhtari K; Le Maréchal C; Marcorelles P
Hum Pathol; 2015 Aug; 46(8):1189-96. PubMed ID: 26037215
[TBL] [Abstract][Full Text] [Related]
12. Neurocutaneous melanosis presenting with hydrocephalus and malignant transformation: case-based update.
Sharouf F; Zaben M; Lammie A; Leach P; Bhatti MI
Childs Nerv Syst; 2018 Aug; 34(8):1471-1477. PubMed ID: 29948137
[TBL] [Abstract][Full Text] [Related]
13. Neurosurgical management of patients with neurocutaneous melanosis: a systematic review.
Rahman RK; Majmundar N; Ghani H; San A; Koirala M; Gajjar AA; Pappert A; Mazzola CA
Neurosurg Focus; 2022 May; 52(5):E8. PubMed ID: 35535823
[TBL] [Abstract][Full Text] [Related]
14. Neurocutaneous melanocytosis (melanosis).
Ruggieri M; Polizzi A; Catanzaro S; Bianco ML; Praticò AD; Di Rocco C
Childs Nerv Syst; 2020 Oct; 36(10):2571-2596. PubMed ID: 33048248
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of central nervous system abnormalities in neurocutaneous melanocytosis.
Ramaswamy V; Delaney H; Haque S; Marghoob A; Khakoo Y
Dev Med Child Neurol; 2012 Jun; 54(6):563-8. PubMed ID: 22469364
[TBL] [Abstract][Full Text] [Related]
16. Leptomeningeal melanomatosis associated with neurocutaneous melanosis: an autopsy case report.
Matsumura M; Okudela K; Tateishi Y; Umeda S; Mitsui H; Suzuki T; Nakayama T; Inayama Y; Ohashi K
Pathol Int; 2015 Feb; 65(2):100-5. PubMed ID: 25521302
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic codon 13 NRAS mutation in a primary mesenchymal brain neoplasm and nevus of a child with neurocutaneous melanosis.
Shih F; Yip S; McDonald PJ; Chudley AE; Del Bigio MR
Acta Neuropathol Commun; 2014 Oct; 2():140. PubMed ID: 25330907
[TBL] [Abstract][Full Text] [Related]
18. Missense mutation of NRAS is associated with malignant progression in neurocutaneous melanosis.
Takahashi H; Natsumeda M; Hara N; Koyama A; Shimizu H; Miyashita A; Satake D; Mouri Y; Tsukano J; Kawabe K; Tsukamoto Y; Okada M; Ogura R; Yuki A; Umezu H; Kakita A; Ikeuchi T; Oishi M
Acta Neuropathol Commun; 2024 Jan; 12(1):14. PubMed ID: 38254245
[TBL] [Abstract][Full Text] [Related]
19. Neurocutaneous melanomatosis with a rapidly deteriorating course.
Chu WC; Lee V; Chan YL; Shing MM; Chik KW; Li CK; Ma KC
AJNR Am J Neuroradiol; 2003 Feb; 24(2):287-90. PubMed ID: 12591651
[TBL] [Abstract][Full Text] [Related]
20. A newborn with neurocutaneous melanocytosis and Dandy-Walker malformation.
De Cock J; Snauwaert J; Van Rompaey W; Morren MA; Demaerel P
Pediatr Neurol; 2014 Mar; 50(3):276-8. PubMed ID: 24321541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
